Mackay Shields LLC Glaukos Corp Transaction History

Mackay Shields LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$73.06 - $97.7 $255,710 - $341,950	-3,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$70.43 - $97.42 $14,086 - $19,484	-200 Reduced 5.41%	3,500 $294,000
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $180,930 - $278,462	3,700 New	3,700 $279,000
Q3 2020 Nov 04, 2020	SELL	$37.23 - $50.97 $264,333 - $361,887	-7,100 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$28.78 - $46.83 $204,338 - $332,493	7,100 New	7,100 $273,000
Q3 2019 Nov 01, 2019	SELL	$58.58 - $83.91 $784,972 - $1.12 Million	-13,400 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$63.59 - $78.71 $852,106 - $1.05 Million	13,400 New	13,400 $1.01 Million

342

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.97B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.